Stay updated on Roxadustat in End-Stage Renal Disease Clinical Trial
Sign up to get notified when there's something new on the Roxadustat in End-Stage Renal Disease Clinical Trial page.

Latest updates to the Roxadustat in End-Stage Renal Disease Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe record now presents details for the completed Phase 2 roxadustat study in participants with end-stage renal disease receiving maintenance hemodialysis, including eligibility criteria, treatment arms, locations, and outcome measures.SummaryDifference85%

- Check19 days agoChange DetectedThe site revision identifier in the footer changed from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check26 days agoChange DetectedA banner announces an NIH website transition and says the agency is using “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check33 days agoChange DetectedThe ClinicalTrials.gov footer now shows revision v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check40 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check61 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the full study record with a basic error view. The additions reflect the error page elements (403, HTML header, Home, Revision: v3.7.0), and the detailed study content has been removed.SummaryDifference21%

Stay in the know with updates to Roxadustat in End-Stage Renal Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Roxadustat in End-Stage Renal Disease Clinical Trial page.